Skip to main content

Table 6 MRI Evaluation (Cross-Sectional Area and Tunnel Dimensions) - Missing/Contaminated Graft Subjects Excluded

From: Xenograft for anterior cruciate ligament reconstruction was associated with high graft processing infection

 

1 Week

 

12 Months

 

24 Months

Allo

Xeno

p-value

 

Allo

Xeno

p-value

 

Allo

Xeno

p-value

CSAmax

74.1 ± 28.6

68.4 ± 21.2

0.403

 

106.9 ± 49.9

121.9 ± 70.4

0.529

 

92.0 ± 32.9

113.8 ± 51.9

0.036*

FT–AP

10.2 ± 1.3

9.9 ± 1.0

0.571

 

9.6 ± 1.7

13.6 ± 2.2

< 0.001**

 

10.2 ± 2.2

11.8 ± 2.6

0.122

FT–ML

10.0 ± 1.2

9.3 ± 0.8

0.096

 

11.2 ± 2.3

14.1 ± 3.2

0.011*

 

9.6 ± 2.0

13.1 ± 2.0

< 0.001**

TT–AP

9.7 ± 1.6

9.1 ± 2.2

0.095

 

10.3 ± 2.7

12.2 ± 1.8

< 0.001**

 

11.4 ± 2.5

13.3 ± 2.2

0.013*

TT–ML

9.4 ± 1.6

9.8 ± 1.7

0.339

 

10.3 ± 2.1

12.5 ± 2.1

< 0.001**

 

10.1 ± 2.0

12.1 ± 1.7

< 0.001**

  1. *p < 0.05; **p < 0.001; CSAmax, Maximum graft cross-sectional area in mm2;FT–AP, Femoral tunnel anterior-posterior in mm; FT–ML, Femoral tunnel medial-lateral in mm; TT–AP, Tibial tunnel anterior-posterior in mm; TT–ML, Tibial tunnel medial-lateral in mm